- Home
- RAPT vs CAAS Comparison
RAPT vs CAAS Comparison
Compare RAPT & CAAS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RAPT
- CAAS
- Stock Information
- Founded
- RAPT 2015
- CAAS N/A
- Country
- RAPT United States
- CAAS China
- Employees
- RAPT N/A
- CAAS N/A
- Industry
- RAPT Biotechnology: Pharmaceutical Preparations
- CAAS Auto Parts:O.E.M.
- Sector
- RAPT Health Care
- CAAS Consumer Discretionary
- Exchange
- RAPT Nasdaq
- CAAS Nasdaq
- Market Cap
- RAPT 117.5M
- CAAS 125.2M
- IPO Year
- RAPT 2019
- CAAS N/A
- Fundamental
- Price
- RAPT $0.92
- CAAS $4.12
- Analyst Decision
- RAPT Buy
- CAAS
- Analyst Count
- RAPT 5
- CAAS 0
- Target Price
- RAPT $5.25
- CAAS N/A
- AVG Volume (30 Days)
- RAPT 1.1M
- CAAS 24.1K
- Earning Date
- RAPT 05-08-2025
- CAAS 05-14-2025
- Dividend Yield
- RAPT N/A
- CAAS N/A
- EPS Growth
- RAPT N/A
- CAAS N/A
- EPS
- RAPT N/A
- CAAS 0.96
- Revenue
- RAPT N/A
- CAAS $678,635,000.00
- Revenue This Year
- RAPT N/A
- CAAS N/A
- Revenue Next Year
- RAPT N/A
- CAAS N/A
- P/E Ratio
- RAPT N/A
- CAAS $4.27
- Revenue Growth
- RAPT N/A
- CAAS 18.33
- 52 Week Low
- RAPT $0.71
- CAAS $3.34
- 52 Week High
- RAPT $4.60
- CAAS $5.37
- Technical
- Relative Strength Index (RSI)
- RAPT 49.00
- CAAS 56.20
- Support Level
- RAPT $0.86
- CAAS $4.01
- Resistance Level
- RAPT $1.27
- CAAS $4.20
- Average True Range (ATR)
- RAPT 0.13
- CAAS 0.16
- MACD
- RAPT 0.01
- CAAS 0.01
- Stochastic Oscillator
- RAPT 34.50
- CAAS 55.32
About RAPT RAPT Therapeutics Inc.
RAPT Therapeutics Inc is a clinical-stage immunology-based biopharmaceutical company. It is focused on discovering, developing, and commercializing oral small-molecule therapies for patients with some unmet needs in oncology and inflammatory diseases. The company pipeline products include FLX475, designed to selectively inhibit the migration of immunosuppressive regulatory T cells into tumors; and RPT193, designed to selectively inhibit the migration of type 2 T helper cells into inflamed tissues.
About CAAS China Automotive Systems Inc.
China Automotive Systems Inc is a holding company. The firm through its subsidiary is a supplier of power steering systems and components to China's automotive industry. Its product offering encompasses a full range of auto parts incorporated into steering systems for both passenger automobiles and commercial vehicles. The company offers four separate series, models of power steering including rack and pinion power steering, integral power steering, electronic power steering and manual steering, steering columns, steering oil pumps, and steering hoses. Geographically, it derives a majority of its revenue from China.